SLGT2i and the Kidney Tweetorial Part 2
Start: Time to #flozinate
When prescribing- mindful for bp management kidney360.asnjournals.org @aishaikh
Start: Time to #flozinate
When prescribing- mindful for bp management kidney360.asnjournals.org @aishaikh
A typical patient included in CREDENCE would lose 4.6 ml/min/year of eGFR if treated with RAASi only, reaching ESKD in 10 years. However, if canagliflozin is added to his treatment, he would only lose 1.85 ml/min/year of eGFR, delaying ESKD by 15 kidney360.asnjournals.org
What other effects? @ChristosArgyrop
Renal transplants get to #flozinate
Final words: SGLT2i are safe and effective down to GFR 20ml/min, though caution in the 20-30 range ( definitely use for GFR >25)
Donβt stop as kidney function declines until start of dialysis
Expect GFR drop, even up to 20-30%
Donβt stop as kidney function declines until start of dialysis
Expect GFR drop, even up to 20-30%
Final words: Despite lack of major impact on A1c, this is an essential medication with proven hard clinical benefit for multiple organ systems. Few side effects; many of those from early studies, including UTIs, fractures, amputations, etc., have not panned out in further studies
SGLT-2 inhibitors should be included in the medication regimen for all our type 2 diabetic patients with kidney disease. SGLT-2 inhibitors are now approved for use in CKD patients without diabetes with proteinuria( eg: IgA Nephropathy).
SGLT-2 inhibitors may be used in diuretic resistant cardio-renal syndrome
SGLT-2 inhibitors can be reserved for refractory SIADH and hypomagnesemia and possible prevention of kidney stones
SGLT-2 can safely be used in renal transplant patients
SGLT-2 inhibitors can be reserved for refractory SIADH and hypomagnesemia and possible prevention of kidney stones
SGLT-2 can safely be used in renal transplant patients
What time is it? Time to #flozinate
End Part 2
End Part 2
Loading suggestions...